The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been down a third of a percent (0.32%) at 8,154 points.

Consumer Staples continue to be the worst performing sector, down 1.7%, with well-known plays Woolworths (ASX:WOW), Bega Cheese (ASX:BGA), and Elders (ASX:ELD) all dragging the local bourse lower. Utilities has been 1.2% softer, followed by Industrials, down 1%.

IT has been the best performer, up 0.4%, followed by Discretionary, up 0.24%, and Real Estate, up 0.15%.

Company News

Imugene (ASX:IMU) has been down 4.3% on its quarterlies. The company reported cash or cash equivalents of $54.3 million, down from $93.1 million in the June quarter.

Imugene has been 4.5 cents.

Mineral Resources (ASX:MIN) has been up 11.3% on release of its quarterlies. The company has agreed to sell its two oil and gas exploration permits in the Perth Basin to Gina Rinehart’s Hancock Prospecting. Hancock will pay Mineral Resources up to $1.1 billion for the permits.

Mineral Resources has been $40.15.

Coles (ASX:COL) has been down 1.1% after releasing its quarterlies before market open. The company delivered a 2.9% increase in total sales to $10.54 billion for the three months ended 29 September. However, the result did not enthuse investors.

Coles has been $17.50.

More From The Market Online
HotCopper Daily Market Trends Graphic

Monday’s HotCopper trends: Electro Optic, BPH, and other daily topics | Jan 12

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front
Lawsuit market concept

GreenX Metals surges +16% as Singaporean court lights way to $380M payout from Poland

GreenX has rocketed more than +15% as a court in Singapore dismissed a trade appeal from…

‘Major scope to keep growing’: Leeuwin’s next Marda drilling to extend mineralisation, increase resource

Drills are firing at Marda again, with Leeuwin Metals restarting its exploration work in Western Australia…
FDA Approval

Imricor Medical Systems runs hard on FDA greenlight for diagnostic catheter

Imricor has won its first keystone FDA clearance, with the U.S. regulator effectively thumbs-upping Imricor's diagnostic…